Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healwell AIHWAIF -5.46%53 EV-to-EBITDA is -112.93 as of Aug. 02, 2026. GuruFocus rates HWAIF with a GF Score™ of 53/100 and a GF Value™ of $2.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Healwell AI ranks worse than 196463.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Healwell AI's enterprise value is $200.90 Mil.
Healwell AI's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.78 Mil. Therefore, Healwell AI's EV-to-EBITDA for today is -112.93.
The historical rank and industry rank for Healwell AI's EV-to-EBITDA or its related term are showing as below:
HWAIF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -438.39 Med: -8.92 Max: 181.56
Current: -109.25
During the past 9 years, the highest EV-to-EBITDA of Healwell AI was 181.56. The lowest was -438.39. And the median was -8.92.
HWAIF's EV-to-EBITDA is ranked worse than 100% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.07
vs HWAIF: -109.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Healwell AI (OTCPK:HWAIF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Healwell AI's PE Ratio (TTM) for today is calculated as:
Healwell AI's share price for today is $0.4518.
Healwell AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.117.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Healwell AI's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Healwell AI's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healwell AI EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healwell AI's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Healwell AI's EV-to-EBITDA falls into.
Healwell AI's current Enterprise Value is $200.90 Mil.
Healwell AI's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healwell AI (HWAIF) has a EV-to-EBITDA of -112.93 as of Aug. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healwell AI. According to the industry distribution chart, Healwell AI ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is Healwell AI's EV-to-EBITDA too high?
Healwell AI's current EV-to-EBITDA is -112.93. Based on the distribution chart, Healwell AI ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Healwell AI has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healwell AI's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Healwell AI ranks #999999 out of 509 companies for EV-to-EBITDA. This places Healwell AI in the lower half of its industry. The industry median EV-to-EBITDA is 11.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.07, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healwell AI. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healwell AI's current EV-to-EBITDA is -112.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healwell AI stock overvalued right now?
Based on GuruFocus' analysis, Healwell AI (HWAIF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.53, compared to a current price of $0.45 — trading 82.1% below its estimated fair value. The current EV-to-EBITDA is -112.93. Healwell AI's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Healwell AI (HWAIF), the current EV-to-EBITDA is -112.93 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healwell AI (HWAIF) Overvalued in 2026?
Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued.
The current stock price of $0.45 is trading 82.1% below its estimated GF Value™ of $2.53.
GuruFocus considers Healwell AI to be Possible Value Trap.
Key valuation signals for HWAIF:
EV-to-EBITDA: -112.93
GF Value™: $2.53 vs. price of $0.45 (82.1% below fair value)
No single metric tells the full story. See the HWAIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
53GF Score
Get the complete analysis for HWAIF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HWAIF has been successfully added to your 
